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Abstract 
Expression of the genes for resistance to heavy metals and metalloids is transcriptionally 
regulated by the toxic ions themselves. Members of the ArsR/SmtB family of small 
metalloregulatory proteins respond to transition metals, heavy metals and metalloids, 
including As(III), Sb(III), Cd(II), Pb(II), Zn(II), Co(II) and Ni(II). These homodimeric 
repressors bind to DNA in absence of inducing metal(loid) ion and dissociate from the DNA 
when inducer is bound. The regulatory sites are often three- or four-coordinate metal 
binding sites composed of cysteine thiolates. Surprisingly, in two different As(III)-responsive 
regulators, the metalloid binding sites were in different locations in the repressor, and the 
Cd(II) binding sites were in two different locations in two Cd(II)-responsive regulators.  We 
hypothesize that ArsR/SmtB repressors have a common backbone structure, that of a 
winged helix DNA binding protein, but have considerable plasticity in the location of 
inducer binding sites.  Here we show that an As(III)-responsive member of the family, 
CgArsR1 from Corynebacterium glutamicum, binds As(III) to a cysteine triad composed of 
Cys15, Cys16 and Cys55.  This binding site is clearly unrelated to the binding sites of other 
characterized ArsR/SmtB family members. This is consistent with our hypothesis that 
metal(loid) binding sites in DNA binding proteins evolve convergently in response to 
persistent environmental pressures. 
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Introduction 
 Arsenic, a toxic metalloid, is currently and has always been ranked first on the Superfund 
List of Hazardous Substances (http://www.atsdr.cdc.gov/cercla/07list.html) in part because of its 
environmental ubiquity. As a consequence, nearly all organisms have genes that confer resistance to 
arsenic. Environmental arsenic is sensed by members of the ArsR/SmtB family of metalloregulatory 
proteins (1-3). These winged helix repressor proteins specifically bind to arsenic and other toxic 
metals. Consequently, they control expression of genes involved in arsenic biotransformation and 
efflux. For example, the ArsR repressor encoded by Escherichia coli plasmid R773 binds to the 
promoter region of its respective ars operon in the absence of As(III) or Sb(III) (4). This homodimeric 
repressor has the sequence Cys32-Val-Cys34-Asp-Leu-Cys37 in the DNA binding domain of each 
monomer (5,6). The three sulfur thiolates of the cysteine residues form a very specific three-
coordinate binding site for the trivalent metalloids As(III) and Sb(III). Binding of metalloids to R773 
ArsR is presumed to induce a conformational change, leading to dissociation from the DNA and 
hence derepression. The Staphylococcus aureus CadC is a Cd(II)/Pb(II)/Zn(II)-responsive member of 
the ArsR/SmtB family that has four cysteine residues in the inducer binding domain (7). Of these 
four cysteine residues, two come from one subunit, while the other two come from the other subunit 
of the homodimer (8,9). The position of this metal binding site in CadC is congruent to that of the 
R773 ArsR but is formed between two monomers. CadC also has a second type of metal binding site 
(DXH(X)10H(X)2E) for Zn(II)  at the dimer interface that is not a regulatory site. This site, however, 
is identical to the regulatory Zn(II) site of SmtB from Synechococcus PCC 7942 (10). Another 
member of the ArsR/SmtB family is the ArsR from Acidithiobacillus ferrooxidans (AfArsR), which 
has three cysteine residues (Cys95, Cys96 and Cys102) at the dimer interface rather than in or near 
the DNA binding domain (11). These three cysteine residues form a three-coordinate or S3 binding 
site for trivalent metalloids (12). While both the As(III) binding site of AfArsR and the Zn(II) binding 
site of SmtB are at the C-terminal dimerization domain, the former is formed of three cysteine 
residues within a single subunit (two sites per dimer), while the latter is formed by four residues, 
two from one monomer and two residues from the other. Thus, metal(loid) binding sites appear to 
arise by convergent evolution, even in homologous proteins.  
In the present study, we focused on two CgArsRs, which regulate expression of the ars operons of 
C. glutamicum, and their arsenic binding properties. C. glutamicum is a gram-positive non-
pathogenic rod-shaped soil bacterium with high intrinsic resistance to arsenic. Analysis of the 
arsenic resistance mechanisms in C. glutamicum revealed the presence of two inducible ars operons 
(ars1 and ars2) that are located distant from each other in the chromosome (13). Expression of both 
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operons is induced by arsenite. Their repressors, CgArsR1 and CgArsR2, which are 66% identical, 
both have three cysteine residues, two N-terminal residues (Cys15 and Cys16) that have no 
counterpart in any of the other characterized members of the ArsR/SmtB family, and a third 
cysteine residue (Cys55) that is near but not within the putative DNA binding domain of the 
regulatory proteins. The positions of these cysteine residues in the two CgArsRs resemble those of 
CadC but appear to have arisen independently. Homology modeling of CgArsR1 suggests two As(III) 
binding sites, each of which is formed by Cys15 and Cys16 from one subunit and Cys55 from the other 
subunit. The results of in vivo and in vitro studies support this hypothesis. Thus, CgArsR1 provides 
a fresh instance of convergent and parallel evolution of metal(loid) binding sites on the built on the 
framework of a common DNA binding protein. 
Materials and Methods  
Strains, media and reagents 
E. coli cells were grown in Luria-Bertani (LB)1 medium at 37 °C. C. glutamicum was grown in 
Tryptone Soya Broth (TSB; TSA when 2% agar was added) at 30 ºC (14). Media were supplemented 
with 100 µg/ml ampicillin, 25 µg/ml kanamycin, 12.5 µg/ml tetracycline or 25 µg/ml chloramphenicol 
(8 µg/ml for C. glutamicum), as required. E. coli strain Top 10 (Invitrogen, Carlsbad, CA) was used 
for plasmid construction and mutagenesis, strain BL21(DE3) (Novagen, Madison, WI), was used for 
protein expression analysis and strain  S17-1 (13) as the donor in conjugation assays. Bacterial 
growth was monitored as A600nm. All reagents were obtained from commercial sources. 
 
Construction of  strains and plasmids and mutagenesis.  
For CgArsR1 and CgArsR2 expression in E. coli, plasmids pETArsR1 and pETArsR2 were 
constructed; in both plasmids the arsR genes were under control of the T7 promoter and fused to a 
C-terminal His-tag.  Cysteine mutants were constructed with these plasmids.   
 For in vivo reporter gene expression,  a C. glutamicum host strain lacking the two 
chromosomal ars operons, including arsR1 and arsR2, was constructed. This strain, termed 2∆ars, 
was made for incorporation of wild type arsR1 and seven mutants in single copy at the original 
position on the chromosome based on the use of the mobilizable plasmid pK18mob (15). A 
bifunctional plasmid containing the original regulatory region from the main operator/promoter site 
of the ars1 operon (o/p) fused in the arsB direction to the egfp2 reporter gene were used for further 
in vivo analysis. 
 The methods for strain and plasmid construction and the for construction of mutants is given 
in Supplementary Materials. 
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Purification of  wild type and mutant CgArsRs.  
E. coli BL21(DE3) bearing pETarsR1, pETarsR2, or the seven arsR1 mutants were cultured and 
induced with 0.3 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). Cells were harvested, washed 
once with a buffer consisting of 50 mM MOPS-KOH, pH 7.5, containing 20% (v/v) glycerol, 0.5 M 
NaCl, 20 mM imidazole and 10 mM 2-mercaptoethanol (buffer A), and suspended in 10 ml of the 
buffer A per gram of cells. The cells were lysed with a French Press at 20,000 p.s.i. with the addition 
of diisopropyl fluorophosphate (2.5 µl/g) and further centrifugation (150,000 x g for 1 h). The 
supernatant was loaded onto a Ni(II)-nitrilotriacetic acid column pre-equilibrated with buffer A at a 
flow rate of 0.5 ml/min. The column was washed with 150 ml of buffer A followed by elution with 60 
ml of buffer A containing 0.2 M imidazole The eluted protein was concentrated with a 10-kDa cut-off 
Amicon Ultracentrifugal filter (Millipore Corp., Billerica, MA) and further purified by gel filtration 
using Superdex 75 (Amersham Biosciences) in a 45 x 1.5cm column with a total bed volume of 80 ml. 
The protein was eluted with a buffer consisting of 50 mM MOPS-KOH, pH 7.5, 0.5 M NaCl, 20 % 
(v/v) glycerol, 0.2 mM EDTA and 2 mM DTT at a flow rate of 0.3 ml/min. CgArsR1 was identified by 
sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE) (16). Fractions 
containing wild type and mutant proteins were concentrated by ultrafiltration centrifugation. 
Protein concentrations were estimated by the method of Bradford (17) or by determining the A280 nm 
using a calculated extinction coefficient of 1615 cm-1 (18). 
 
Crosslinking assays.  
Dibromobimane (bBBr) (Invitrogen) crosslinking was performed as described (8). CgArsR1 was 
reduced in presence of 2 mM Tris(2-Carboxyethyl) phosphine (TCEP) on ice for 30 minutes. 
Reductants were removed by dialysis prior to the assay. Purified CgArsR1 (30 µM, except for C15A, 
which was 100 µM) was incubated with a 3- to 10-fold molar excess of bBBr. Samples were analyzed 
by SDS-PAGE using 16% gels. The gels were visualized under UV365nm light and then stained with 
Coomassie Blue. 
 
X-ray Absorption Spectroscopy (XAS).  
Purified wild type and mutant ArsR1 at 4 mM concentration were incubated on ice for 90 min with 
2-3 mM sodium arsenite in a buffer consisting of 50 mM MOPS-KOH, pH 7.5, and 0.5 M NaCl. 
Glycerol, 30% v/v final concentration, was added and As-loaded protein was injected into Lucite cells 
covered with Kapton tape. Sample cells were flash frozen in liquid nitrogen. XAS data were collected 
at the Stanford Synchrotron Radiation Laboratory (SSRL) on beamline 9-3 in a manner previously 
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described (12). Data reduction and analysis was performed using the EXAFSPAK software suite 
(www-ssrl.slac.stanford.edu/exafspak.html). Prior to data reduction and averaging, each 
fluorescence channel of each scan was examined for spectral anomalies. Published XAS spectra 
represent the average of 5 scans. Data reduction involved fitting the pre-edge spectral region with a 
second order polynomial and the EXAFS region with a cubic spline constructed of three regions. 
Following spline subtraction, EXAFS data were converted into k space using an E0 at 11885 eV.  The 
k3 weighted EXAFS was truncated at 13.0 Å-1 (due to monochromator glitches at higher k), Fourier 
transformed and simulated. The final published fitting results are from analysis of the raw 
unfiltered data.  Data were fit using single scattering amplitude and phase functions generated 
using the Feff 7.2 for theoretical model generation (19). Single scattering Feff models were 
calculated for oxygen, sulfur and arsenic coordination to simulate arsenic-nearest neighbor ligand 
scattering.  Values for the scale factor (Sc) and E0, obtained previously from fitting 
crystallographically characterized As models compounds, were equal to 0.98 and -10, respectively 
(20). During the fitting analysis, the scale factor and E0 were fixed.  The coordination number was 
fixed but manually varied at half integer values.  Values for the bond length and Debye-Waller 
factor were allowed to vary freely. The lowest mean square deviation between data and fit, corrected 
for the number of degrees of freedom, (F’) was used to judge best-fit EXAFS simulations and to 
justify addition of supplementary interactions within the simulation. 
 
DNA footprinting. 
 DNA fotprinting was performed as described (12). Complementary DNA primers in which one was 
labeled at the 5’ end with wellRED D3 fluorescence dye (Integrated DNA Technologies, Coralville, 
IA), as indicated, were used to amplify the C. glutamicum ars1 o/p) region. Two pairs of primers 
were used, one for determining the arsRB direction, and the other for the arsBR direction. arsRB. 
After optimization, a high molar excess of CgArsR1 was added at room temperature for 30 min. As a 
negative control 5 µM BSA was used in place of CgArsR.  The samples were loaded into 96-well 
plates and assayed with a CEQ 2000XL DNA sequencer (Beckman Coulter, Fullerton, CA). The data 
were analyzed with CEQ 2000 fragment analysis software. 
 
DNA mobility shift assays.   
DNA mobility shift assays were performed as described (21). Two probes corresponding to the 
arsR-arsB intergenic region from operon ars1 (igR1B1) and  ars2 (igR2B2) were PCR-amplified from 
C. glutamicum ATCC13032 chromosomal DNA.  
 
Evolution of metal(loid) binding sites in transcriptional regulators  |  E. Ordóñez, et. al 
 
DIGITALCOMMONS@WSU  |  2008 
 
7
DNA binding by fluorescence anisotropy.   
DNA binding studies by fluorescence anisotropy were performed as described (12) using a Photon 
Technology International spectrofluorimeter fitted with polarizers in the L format. Complementary 
30-mer oligonucleotides, one of which was labeled at the 5’ end with carboxyfluorescein (FAM), were 
synthesized (Integrated DNA Technologies, Inc,) based on the DNA footprinting results. Wild type or 
mutant CgArsR1s were titrated with 0.4 ml of 30 nM fluorescein-labeled ars1 o/p DNA. Changes in 
anisotropy were calculated after each addition using the supplied Felix32 software. To measure 
DNA-dissociation of CgArsR1 upon binding to As(III)/Sb(III), 30 nM of FAM-labeled DNA was 
saturated with 10 µM  wild type or mutant CgArsR1. CgArsR1 was treated with methyl 
methanethiosulfonate (MMTS) to modify the cysteine thiolates to -S-S-CH3.  Dissociation of 
CgArsR1 was induced by addition of varying amounts of As(III) or Sb(III). 
 
Results 
CgArsR1 and CgArsR2 have atypical metalloid binding sites.  A structure-based multiple 
alignment of CgArsR1 and CgArsR2 with other ArsR homologues and CadC was performed using 
the structure of CadC (9) (Fig. 1A). CgArsR1 and CgArsR2 are 66% identical to each other and 
exhibit high similarity to other members of the ArsR/SmtB family. Notably, both CgArsR1 and 
CgArsR2 lack the typical Cys32-Cys34-Cys37 three-coordinate As(III) binding site of the well-
characterized R773 ArsR.  They also lack the Cys95-Cys96-Cys105 As(III) binding site of AfArsR (12).  
CadC binds Cd(II) in a four-coordinate binding site composed of four cysteine residues. CadC has a 
second, nonregulatory four-coordinate Zn(II) binding site comprised of residues Asp-101 and His-103 
from one monomer and His-114' and Glu-117' from the other monomer. The two CgArsRs lack the 
acidic and histidine residues of those sites as well.  How do these ArsRs respond to environmental 
As(III) and where are the metalloid binding sites?  Although they lack the binding sites identified in 
homologous metalloregulators, they have three cysteine residues, Cys15, Cys16 and Cys55 that, from 
the alignment, do not correspond to metal(loid) ligands of homologues.  From the structure-based 
alignment with CadC, a homology model of CgArsR1 was constructed (Fig. 1B).  Like CadC, 
CgArsR1 has a putative helix-turn-helix DNA binding domain consisting of α4 and α5.  In CadC the 
Cd(II) binding domain is composed of Cys58 and Cys60 in α4 of one subunit and Cys7 and Cys11 from 
the N-terminal region of the other subunit. While CgArsR1 has no corresponding cysteine residues, 
Cys55 is proposed to be located just before α4, and Cys15 and Cys16 are in α1. Either Cys15 or Cys16 
can be positioned close enough to Cys55 to form a two-coordinate complex with As(III). Since the side 
chains of Cys15 or Cys16 would face in opposite directions, the α1 helix would have to be unraveled 
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from the N-terminal end to allow them to form a three-coordinate complex with Cys55 (Fig. 1C). Our 
working hypothesis, therefore, is that these three cysteine residues form a three-coordinate As(III) 
binding site, where Cys15 and Cys16 come from one subunit and the Cys55 from the other. The 
experiments below were designed to test that hypothesis. 
 
Fig. 1.  Multiple alignment of CgArsR homologues and homology modeling.  (A):  Representative ArsR 
homologues (accession numbers in parentheses) are from: plasmid pI258 CadC (P20047), Synechocystis sp. 
PCC 7942 SmtB (P30340), plasmid R773 ArsR (P15905), C. glutamicum CgArsR1 (YP_225794) and CgArsR2 
(NP_599514), A. ferrooxidans AfArsR (AAF69241), and Mycobacterium tuberculosis H37Rv CmtR 
(NP_216510).  The structure based multiple alignment was calculated using 3DCoffee (Pubmed id 15201059). 
(B): Modeling of As(III)-free CgArsR was performed with the SWISS-MODEL  (Pubmed id : 12824332)(26), 
using the crystal structure of CadC (9) as template. The two monomers are colored in purple (subnunit a) and 
green (subunit b), respectively. The cysteines are shown in ball-and-sticks. The DNA binding domain is α4-
turn-α5. The model was drawn using PyMOL (28). The side chain sulfur atoms of Cys15, Cys16 and Cys55 are 
shown as yellow spheres. (C): Binding is proposed to occur in two steps:  (1) As(III) (blue sphere) binds first to 
the thiolates of Cys55 of one subunit and either Cys15 or Cys16 (shown here for only Cys15) in α1 of the other 
subunit, forming a low affinity S2O site, and (2) the end of α1 unravels to allow the adjacent cysteine residue 
to become the third ligand to As(III), forming a high affinity S3 site. The model of the As(III)-bound form was 
built by manually adjusting the N-termini so that the geometry of As(III) coordination derived from the 
EXAFS results. 
 
 
Fig. 1 
B C 
A 
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The As(III) binding site in CgArsR1 is composed of three sulfur thiolates. Binding of As(III) and 
the geometry of the binding site was analyzed by XAS. Near edge x-ray absorption fine structure 
analysis indicates arsenic in purified wild type CgArsR1 is stably bound as As(III) (data not shown). 
The observed value for the first inflection point energy is 11,866 eV, consistent with the observed 
values for As(III) binding sites (20). Simulation analysis of the EXAFS data for CgArsR1 was best fit 
with a single nearest neighbor ligand environment constructed with only three sulfur atoms (Figure 
2A and B). The average bond length of As-S was calculated to be 2.25 Å. Attempts to simulate these 
data with a mixed sulfur and oxygen nearest neighbor environment were unsuccessful. These 
results are consistent with an As(III) binding site composed of the sulfur thiolates of Cys15, Cys16 
and Cys55 (Fig. 2C).  
 
Fig. 2.  EXAFS and Fourier transforms of CgArsR1 XAS data. EXAFS spectra of 
CgArsR1 with bound As(III) (A) and the corresponding Fourier transform (B) are shown as dashed lines, with 
the simulations of EXAFS and FT data shown as solid lines. A schematic representation of the putative 
coordination environment in CgArsR1 is shown in (C). Sample preparation was as described under Materials 
and Methods. 
 
Contribution of CgArsR1 cysteine residues to metalloregulation in vivo.  To examine whether 
Cys15, Cys16 and Cys55 are involved in As(III) sensing in vivo, the double ars-operon deleted 2∆ars 
was constructed. In an additional step, wild type and mutant copies of the arsR1 gene were 
integrated into the chromosome of C. glutamicum 2∆ars at the same position of the original ars1 
operon, creating strains encoding wild type ArsR1, (2∆arswt) and variants C15S, C16S, C55S, 
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C15/16S, C15/55S, C16/55S or C15/16/55S. These strains were used as host for the bifunctional 
mobilizable plasmid pECGFPars, which contains the original ars1 o/p regulatory region fused in the 
arsB direction to the reporter gene egfp2 (a variant of gfp) that has been commonly used for 
expression analysis in corynebacteria.  
Cells of C. glutamicum lacking the two ars operons had constitutive GFP expression (Fig. 3).  Cells 
with wild type arsR1 expressed egfp2 at repressed levels in the absence of metalloid, and addition of 
either As(III) or Sb(III) induced expression. As(III) induced well at 10 µM.  Sb(III) is not taken up 
ver well by C. glutamicum and is  therefore not as effective as an inducer as As(III).  Even so, Sb(III) 
induced more at 30 µM than at 10 µM. All of the C. glutamicum strains containing the single, 
(C15S, C16S and C55S), double (C15/16S, C15/55S and C16/55S) or triple (C15/16/55S) arsR1 
mutants repressed the egfp2 expression, demonstrating that the mutants ArsR1s were capable of 
binding to the ars1 o/p.  In contrast, no induction was observed with any of the mutants, suggesting 
that they do not dissociate from the DNA in the presence of As(III) (Fig. 3A) or Sb(III) (Fig. 3B). 
These results are consistent with the hypothesis that each of the three cysteine residues contributes 
to the inducer binding site. 
 
Fig. 3. In vivo regulation of egfp2(gfp) expression from the arsB promoter using CgArsR1 and the seven Cys 
mutants in presence or absence of As(III) or Sb(III) Construction of C. glutamicum 2∆ars, further integration 
of arsR1 derivatives, mobilization of the reporter gene (gfp), sample preparation and fluorescence 
measurements were performed as described under Materials and Methods. (A) Strains C. glutamicum 2∆ars 
(Control), 2∆ars containing the arsR1 integrated (2∆arswt; WT), the single (C15S; C16S; C55S), double 
(C15/16S; C15/55S; C16/55S) or triple (C15/16/55S) arsR1 mutant integrated were analyzed in the absence of 
arsenite (left bars) or the presence of 10 µM (middle bards) or 30 µM (right bars) As(III) or (B) in the absence 
(left bars) or presence of 10 µM (middle bars) or 30 µM (right bars) Sb(III). Sample preparation and 
fluorescence determination was performed as described under Materials and Methods. 
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DNA binding properties of CgArsR1 and CgArsR2 and contribution cysteine residues to 
metalloregulation in vitro. To examine the DNA binding properties of CgArsRs and the contribution 
of cysteine residues to metalloid-induced dissociation from the DNA, protein-DNA interactions were 
analyzed in several ways. First, binding was examined by DNA mobility shift assays. In the two C. 
glutamicum ars operons the gene organization is different from the R773 arsRDABC in that the 
corresponding arsRs genes are expressed divergently from the other ars genes. The ability of 
CgArsR1 and CgArsR2 to bind to their own ars intergenic regulatory DNA (in cis) and also their 
ability to bind to the other ars intergenic DNA (in trans) were determined. In both cases bands 
corresponding to the amplified intergenic regions from either ars1 (igR1B1) (Fig. 4) or ars2 (igR2B2) 
(data not shown), respectively, were retarded by either CgArsR1 or CgArsR2. These probes were 150 
bp (igR1B1) and 180 bp (igR2B2) and contained a portion of the arsR gene as well as the sequence 
past -70.  As shown below, this probe has two sequences that footprint with CgArsR1, but only the 
upstream sequence binds with low affinity and should not affect DNA mobility in this assay.  
Instead, the slight differences in mobility can be attributed to increasing concentrations of 
repressor. Either repressor bound to either promoter site, in spite of the fact that they have different 
palindromic sequences in their intergenic regions.  Since both repressors appeared to have similar 
binding abilities, subsequent biochemical analysis was performed only with CgArsR1. 
 
Fig. 4.  Electrophoretic mobility shift assays of CgArsR-DNA binding. The igR1B1 PCR-amplified band (177-
bp) was assayed in presence (+) or absence (-) of CgArsR1 or CgArsR2 at the indicated concentrations of 
protein. In each case a retarded band was observed upon PAGE using a 10% non-denaturating gel when the 
repressor protein was present. 
Fig. 4 
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 Second, to examine DNA binding properties in more detail, the sequence in the intergenic 
region between the arsR1 and arsB1 genes to which CgArsR1 binds was determined by DNase I 
footprinting (Fig. 5). CgArsR1 were observed to bind to two regions of 30 base pairs, from -7 to -37 
bp, and -47 to -77, each relative to the start of arsB.  
 
 
 
Fig. 5.  DNA footprinting. (A) DNase I foot printing was performed as described under Materials and Methods 
using WellRED D3 dye labeled double stranded DNA. The sizes of major fragments in nucleotides are shown 
at the top of the peaks. The sequences bound to CgArsR1 are shown between the arrows. The positions -7, -37, 
-47 and -77 indicate nucleotides upstream of the start of the arsB gene.  (B) The sequence of the double 
stranded DNA is shown with the binding sequences boxed. The highlighted sequences indicate a palindromic 
repeat in the intervening region between the arsR and arsB genes of the ars1 operon. The start sites of the 
arsR and arsB genes are indicated. 
 
 
 
 
-7 -37 -47 -77 
Fig. 5 
A 
B 
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DNA binding was further analyzed by fluorescence anisotropy (Fig. 6) Double stranded 
oligonucleotides of 30 bp each corresponding to the -7 to -37 and -47 to -77 sequences were labeled 
with FAM for anisotropy measurements.  The free probes tumble rapidly in solution and hence have 
relatively low optical anisotropy. Binding of CgArsR1 and hence the emitted light is partially 
polarized. Dissociation of the repressor from the DNA reverses the increase in polarization. 
CgArsR1 bound strongly to the –7 to -37 probe (Fig. 6A). In spite of the footprinting results, 
CgArsR1 bound only weakly to the –47 to -77 probe.  It is possible that binding of the repressor to 
the -7 to -37 region cooperatively increases binding to the -47 to -77 region. Wild type CgArsR1 
bound to the -7 to -37 probe with an apparent affinity of 0.15 µM.  Each single, double and triple 
cysteine mutant bound to the -7 to -37 probe, although with reduced affinity ranging from 0.5 µM to 
2 µM.  When the cysteine residues in wild type CgArsR1 were chemically modified with methyl 
methanethiosulfonate (MMTS), the affinity of the modified repressor was similar to that of the 
cysteine mutants. These results demonstrate that none of the cysteine residues are required for 
binding to ars1 o/p DNA. 
 
Fig. 6.  CgArsR1 binding to DNA assayed by fluorescence anisotropy. DNA binding assays were performed as 
described under Materials and Methods. (A) Fluorescently labeled double stranded DNA was titrated with the 
indicated concentrations of wild type CgArsR1 (), MMTS-modified wild type CgArsR1 (), C15S (), C16S 
(), C55S(), C15/16S (), C15/55S (), C16/55S (), C15/16/55S (),wild type CgArsR1 preincubated with 
0.3 mM sodium arsenite (∇).  (B) Double stranded DNA with bound wild type CgArsR1 was titrated with the 
indicated concentrations of sodium arsenite without GSH in the assay buffer () and with 2 mM GSH (), 
C16S () or MMTS-modified wild type CgArsR1 () titrated with the indicated concentrations of sodium 
arsenite. (C) Double stranded DNA with bound wild type CgArsR1 (), CgArsR1 with 2 mM GSH () or C16S 
() titrated with the indicated concentrations of potassium antimonyl tartrate. 
 
 
Fig. 6 
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The effect of binding of As(III) (Fig. 6B) or Sb(III) (Fig. 6C) on dissociation of the repressor from 
the ars1 o/p DNA was assayed by fluorescent anisotropy. Wild type CgArsR1 exhibited half-maximal 
dissociation at 0.15 mM As(III). The concentration of Sb(III) required for half-maximal dissociation 
was approximately 10 µM. For unexplained reasons, addition of reduced glutathione increased the 
apparent affinity for As(III) but not Sb(III). In contrast to the in vivo results (Fig. 3), Sb(III) was 
more effective in vitro than As(III). This may represent relatively poor uptake of Sb(III) in vivo 
compared with As(III). However, none of the single, double or triple mutants dissociated from the 
DNA with concentration of As(III) or Sb(III) as high as 1 mM. These data indicate that each of the 
three cysteine residues is necessary for dissociation from the DNA and hence derepression. 
 
Cys15 and Cys16 from one subunit is in proximity of Cys55 in the other subunit. In CadC the Cd(II) 
binding site is composed of two cysteine residues from the N-terminal region of one subunit and two 
cysteine residues from α4 of the DNA binding domain of the other subunit of the homodimer (9). In 
the homology model of CgArsR1 built on the CadC structure, the three-coordinate As(III) binding 
site is proposed to consist of Cys15 and Cys16 from one subunit and Cys55 from the other (Fig. 1C). A 
testable prediction of that model is that the thiolates of either Cys15 or Cys16 should be close enough 
to the thiolate of Cys55 to crosslink with a bifunctional thiol reagent such as bBBr, which forms a 
fluorescent adduct following reaction with two thiolates that are within 3-6 Ǻ of each other (22). If 
so, then the homodimer would not dissociate upon SDS PAGE following bBBr treatment. Purified 
wild-type CgArsR1 migrated as a monomer on SDS PAGE (Fig. 7A, lane 2). Following treatment 
with bBBr, a portion of the protein migrated as a fluorescent dimer (Fig. 7A and B, lanes 1). The 
band corresponding to the monomer was also fluorescent, which could result from bimane adduct 
formation between Cys15 and Cys16 from the same monomer or from formation of bimane adducts 
between cysteine thiolates and solvent molecules.  The single C15S, C16S and C55S mutants 
similarly formed fluorescent dimers (Fig. 7B, lanes 3, 5 and 7). The triple C15/16/55S mutant did 
not dimerize or become fluorescent (data not shown). These results indicate that both Cys15 and 
Cys16 from one subunit are within 3-6 Ǻ of the thiolate of Cys55 in the other subunit (but not 
necessarily simultaneously, as suggested in Fig. 1C).   These results are consistent with the 
hypothesis that the CgArsR1 As(III) binding site is composed of two cysteine residues from one 
subunit and one cysteine residue from the other. 
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Fig. 7.  Reaction of CgArsR1 with dibromobimane.  Wild-type CgArsR1  (lanes 1 and 2), single mutants 
C15S (lanes 3 and 4), C16S (lanes 5 and 6) and C55S (lane 7 and 8)  were analyzed by SDS PAGE on 16% 
polyacrylamide gels with (lanes 1, 3, 5 and 7)  or without (lanes 2, 4, 6 and 8) reaction with dibromobimane. 
The gels were visualized on a transilluminator for fluorescence (B) and stained with Coomassie blue (A).  The 
positions of the 13-kDa monomer and 26-kDa dimer are indicated by arrows. 
 
Discussion 
The ArsR/SmtB family of metalloregulatory proteins is large and diverse, with more than 3000 
members identified in archaea, prokaryotic genomes and plasmids.  They respond to a number of 
transition metals, heavy metals and metalloids (1-3). Only a few have been examined at the 
structural level (9,23,24), but a striking observation is that, while they all appear to have evolved 
from a common winged helix repressor, their metal(loid) binding appear to have evolved 
independently from each other and are in different spatial locations in their respective structures 
(3,12,25) (Fig. 8). These inducer binding sites can be located either near the DNA binding domain, 
such as found in R773 ArsR or CadC, or near the C-terminal dimer interface, as in SmtB, CmtR or 
AfArsR. For softer metals and metalloids such as As(III), Sb(III) and Cd(II), the binding sites are 
composed of three or four cysteine residues for As(III) or Cd(II).  For harder metals such as the 
Zn(II) binding site of SmtB and CadC, carboxylate oxygens and imidazole nitrogens form the sites. 
Moreover, the binding sites are in some repressors composed of residues within a single subunit 
Fig. 7 
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(R773 ArsR or AfArsR) or sometimes between subunits of the homodimer (CadC, SmtB or CmtR).  
Finally, the metal(loid) binding ligands are frequently located at the beginning or end of helices, 
where unraveling these helices may induce dissociation of the repressor from the operator/promoter 
DNA. Ends are preferred because it would undoubtedly take more energy to break the helix if they 
were located in the middle. 
However, that reasoning is based on only a small number of examples from the thousands of 
homologous sequences in databases. For that reason, we characterized two other member of the 
ArsR/SmtB family encoded by the two ars operons of C. glutamicum (13).  As(III) induces gene 
expression in cells of C. glutamicum, justifying their designations as As(III)-responsive repressors 
CgArsR1 and CgArsR2.  It was clear from the structure-based alignment that they lack the As(III) 
binding sites of the other two known As(III)-responsive repressors from plasmid R773, which has an 
S3 site in the DNA binding site, and A. ferrooxidans, which has an S3 site in the C-terminal 
dimerization domain.   
From the near edge x-ray absorption fine structure results, CgArsR1 also binds As(III), and the 
EXAFS shows that it is an S3 site.  Since CgArsR1 has only three cysteine residues, Cys15, Cys16 and 
Cys55, these are the logical candidates for the S3 site. Consistent with this idea, mutations in any of 
the three resulted in loss of As(III)-responsiveness in vivo and loss of dissociation from the ars 
operator/promoter DNA in vitro.  The CgArsR1 model suggests that the S3 site is formed 
intermolecularly between Cys15 and Cys16 in α1 and Cys55, which is located just before α4 of the 
helix-turn-helix DNA binding domain.   This is reminiscent of the S4 Cd(II) binding site of CadC, but 
none of the cysteine residues in CgArsR1 align with those in CadC.  Thus, it is highly likely that the 
As(III) binding site in CgArsR1 evolved independently of the As(III) binding sites in R773 ArsR or 
AfArsR or the Cd(II) binding sites of CadC or CmtR. 
As discussed above, we have noted that the metal(loid) binding site in each of these repressors 
have ligands that are located near the start or end of an α helix and have suggested that unraveling 
of a helix from one end is involved in the conformational change that dissociates the repressor from 
its cognate DNA sequence.  We propose that this is the mechanism of derepression in CgArsR1. 
While recognizing that a homology model is not a structure, it predicts that Cys15 and Cys16 are 
close enough to Cys55 to simultaneously coordinate to As(III), and the dBBr crosslinking results 
support that idea.  How do they form a three-coordinate binding site?  Cys15 and Cys16 are a vicinal 
cysteine pair, which should form one of the strongest types of As(III) binding sites. However, they 
are predicted to be at the beginning of α1 (Fig. 1C), and their thiolates cannot approach each other 
closely enough to bind As(III) two-coordinately. We propose that Cys55 and either Cys15 or Cys16 first 
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bind As(III) in a weak complex. This is followed by unraveling the beginning of α1, exposing the 
third thiolate, which then completes the high affinity As(III) binding site and dissociation of 
CgArsR1 from the DNA. 
 In summary, the identification of a third As(III)-responsive repressor in which the inducer 
binding site is different from that of R773 ArsR, AfArsR, CadC, SmtB or CmtR supports our 
hypothesis that the binding sites are the result of independent and recent evolutionary events.  Just 
as animals have a body plan of bilateral symmetry, these repressors are built using a pre-existing 
scaffold of an ancestral winged helix DNA binding protein. Just as animals such as birds, bats, 
flying squirrels and flying fish evolved wings convergently, so too have the inducer binding sites of 
ArsR/SmtB homologues evolve in diverse locations on the surface of the protein in response to 
environmental pressures by spatial positioning of residues to form three- or four-coordinate 
metal(loid) binding sites (Fig. 8). 
 
Fig. 8.   Location of metal(loid) binding sites in ArsR/SmtB repressors.  Metal(loid) binding sites in members 
of ArsR/SmtB family of repressor proteins are shown on a surface model of the CadC aporepressor structure 
either by coloring CadC residues corresponding to each binding site as identified from the structure-based 
Fig. 8 
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alignment (Fig. 1A), or, in the case of CmtR, by overlaying the two structures. The S3 As(III) binding site of 
the R773 ArsR (red) formed within each monomer overlaps with the corresponding S4 Cd(II) binding site of 
CadC (yellow) formed between the N-terminus of one subunit and the DNA binding domain of the other 
subunit. Zn(II) binding sites of CadC and SmtB (cyan) formed between the antiparallel C-terminal α6 helices 
also overlap. The S3 binding sites of CgArsR1 (green), CmtR (blue) and AfArsR (purple) are at a variety of 
locations distributed over the surface of the repressor.   
 
Footnotes 
1Abbreviations: LB, Luria broth;  TCEP, tris-(2-carboxyethyl) phosphine; IPTG, isopropyl-beta-D-
thiogalactoside; MMTS, methyl methanethiosulfonate; bp, nucleotide base pair; SDS, sodium 
dodecyl sulfate; PAGE, polyacrylamide gel electrophoresis; XAS, X-ray absorption spectroscopy; 
EXAFS, extended X-ray absorption fine structure; bBBR, dibromobimane. 
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Supplemental Information 
Materials and Methods 
 
Plasmid construction and mutagenesis. For CgArsR1 and CgArsR2 expression in E. coli, plasmids 
pETArsR1 and pETArsR2 were constructed; in both plasmids the arsR genes were under control of 
the T7 promoter and fused to a C-terminal His-tag. arsR1 and arsR2 were amplified by polymerase 
chain reaction (PCR) using chromosomal DNA from C. glutamicum ATCC 13032 as template and 
two pairs of the following primers: for arsR1 the forward and reverse primer pair was: 5’-TAA TTT 
AAA CCA TGG CCA CTC TCC ACA CAA TTC-3’ (DraI and NcoI targets underlined) and 5’-TAA TTT 
AAA CTC GAG TAA TTC CAT TGA GCC GAT C-3’. (DraI and XhoI targets underlined) whereas for 
arsR2 the forward and reverse primer pair was: 5’-CAT GCC ATG GAT GAC CGC ACC CAT CC-3’ 
(NcoI target underlined) and 5’-CCG CTC GAG TCC GAT TTG CAG GAT TG-3’ (XhoI target 
underlined). The amplified fragments (360 and 357 base pairs (bp), respectively) were gel purified, 
digested (NcoI and XhoI) and cloned into pET28a (Novagen), obtaining plasmids pETarsR1 and 
pETarsR2. Cysteine-to-serine mutants for the arsR1 gene were constructed as follows: the first PCR 
step was achieved for each mutant using two set of primers: (i) the common arsR1 forward primer 
and a specific reverse primer for each mutant: for C15S, 5’-GCA AGG GTG CAA GAC TCG GTT GG-
3’; for C16S, 5’-GCA AGG GTG GAA CAC TCG GTT GG-3’; for C55S, 5’-CTT ACA GGC CCG GAC 
CCT CCC-3’; and for C15/16S, 5’-GTA GCA AGG GTG GAA GAC TCG GTT GG-3’ (underlined 
nucleotides indicate the mutagenic changes); (ii) the common arsR1 reverse primer and a specific 
forward primer for each mutant: for C15S, 5’-CCA ACC GAG TCT TGC ACC CTT GC-3’; for C16S, 
5’-CCA ACC GAG TGT TCC ACC CTT GC-3’; for C55S, 5’-GGG AGG GTC CGG GCC TGT AAG-3’; 
and for C15/16S, 5’-CCA ACC GAG TCT TCC ACC CTT GCT AC-3’. In the second step, the two PCR-
amplified fragments for each mutant were used as template for a new PCR amplification, where the 
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forward and reverse arsR1 primers were used.  The double cysteine-to-serine mutants C15/55S, 
C16/55S and the triple cysteine-to-serine mutant C15/16/55S, were constructed using a second 
round of PCR, where the DNA fragments corresponding to C15S, C16S and C15/16S mutants were 
used, respectively, as template. Two pairs of primers were used in the first step of PCR 
amplification: (i) the pair including the arsR1 forward primer and the C55S reverse primer. (ii) the 
pair containing the C55S forward primer and the reverse arsR1 primer. The seven resulting 360-kbp 
amplified fragments were digested with NcoI and XhoI and ligated into the same sites in pET28a, 
obtaining plasmids pETC15S, pETC16S, pETC55S, pETC15/16S, pETC15/55S, pETC16/55S and 
pETC15/16/55S. All constructions and mutations were confirmed by sequencing. 
 
Construction of strains and plasmids for in vivo analysis of wild type and mutant cgArsR1 genes.  
The overall strategy was to construct a C. glutamicum host strain lacking the two chromosomal ars 
operons, including arsR1 and arsR2. This strain, termed 2∆ars, was made for incorporation of wild 
type arsR1 and seven mutants in single copy at the original position on the chromosome based on 
the use of the mobilizable plasmid pK18mob (15). A bifunctional plasmid containing the original 
regulatory region from the main operator/promoter site of the ars1 operon (o/p) fused in the arsB 
direction to the egfp2 reporter gene were used for further in vivo analysis. 
 C. glutamicum strain 2∆ars was constructed using the double recombination method based 
on the use of pK18mobsacB derivatives that are not replicable in C. glutamicum and allow for 
marker-free deletion of the target genes (27). After mating, transconjugants lacking the sacB gene 
by a double recombination event can grow in complex media containing 10% sucrose. Clones lacking 
kanamycin resistance were selected, confirming the double recombination event. Finally the 
selected clones were analyzed by both Southern and PCR to confirm that the entire ars1 and ars2 
operons were deleted. Plasmids pKSars1 and pKSars2, respectively, were constructed for deletion of 
the ars1 and ars2 operons. In both cases they contained the upstream and downstream operon 
fragments fused for deletion purposes. The upstream fragment for pKSars1 was obtained by PCR 
amplification using a forward upstream primer 5’-TAA TTT AAA GAA TTC GAT GGA AGC TTC 
GTT CCA GGT CCC AG-3’ (DraI and EcoRI sites underlined) and a reverse primer 5’-GAA CAA TAC 
ATC TCA TGA CGG ATC CTT TCC AGA ATG CTT TCA TG-3’ (BamHI site underlined), whereas 
downstream forward primer 5’-CAT GAA AGC ATT CTG GAA AGG ATC CGT CAT GAG ATG TAT 
TGT TC-3’ (BamHI site underlined) and reverse primer 5’-TAA TTT AAA AAG CTT GAT GTC GAT 
GAC CCT CTG TTT GAACGC GC-3’ (DraI and HindIII sites underlined) were used to amplify the 
downstream sequence of ars1. Both PCR-amplified fragments were gel purified and used as 
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template for the second PCR amplification step, but in this case using the previously mentioned 
upstream forward and downstream reverse primer pair. The final amplified band was gel purified, 
EcoRI/HindIII double digested and ligated into pK18mobsacB, obtaining pKSars1.  
 Plasmid pKSars2 was made in an equivalent way as follows: for the upstream PCR-
amplification fragment, the forward primer was 5’-TAA TTT AAA GAG CTC TTT TTG TTG GAC 
TGG TGA ATC TTT TC-3’ (DraI and SacI sites underlined), and the reverse primer was 5’-TAA TTT 
AAA TCT AGA TAA ATA GAT ATA GAA CAC ATT CTA TTG CAG GG-3’ (DraI and XbaI sites 
underlined), whereas for the downstream sequence, the forward primer was 5’-TAA TTT AAA TCT 
AGA AAA AGG GGC ATG CAG CAA TAA CTT G-3’ (DraI and XbaI sites underlined), and the 
reverse primer was 5’-TAA TTT AAA AAG CTT CTA CTC TAT GAT CGC GAT CTA CCT C-3’ (DraI 
and HindIII sites underlined). The amplified fragments were subsequently digested (SacI/XbaI for 
upstream and XbaI/HindIII for downstream) and cloned into pK18mobsacB by a two-step 
subcloning strategy, generating plasmid pKSars2. Plasmids pKSars1 and pKSars2 were 
independently used to transform E. coli S17-1 and further mobilized to C. glutamicum RES167 (13). 
Once the single ars operons deleted strains (C. glutamicum ∆ars1 or ∆ars2) were obtained, the ∆ars1 
strain was used as host for a new assay, where pKSars2 was used for the second deletion, finally 
obtaining the double deleted strain C. glutamicum 2∆ars.   
 Chromosomal integration as single copy of the wild type and mutant arsR1s was performed 
via pK18mob following a two step strategy involving first subcloning of the upstream ars1 fragment, 
amplified as described, gel purified and digested (EcoRI/BamHI) for further subcloning into 
pK18mob, obtaining plasmid pKars1up. This fragment was used to direct the further integration of 
the vector at the correct position. The second step involved amplification of the various arsR1 genes 
fused to the original arsR1 regulatory regions. Wild type arsR1, including the ars1 o/p region, was 
amplified from chromosomal DNA using an integrated fusion reverse primer 5’-TAA TTT AAA AAG 
ATG GCG ACA CCT TTC G-3’ (DraI and HindIII sites underlined) and a forward primer 5’-TAA TTT 
AAA GGA TCC TCA TAA TTC CAT TGA GC-3’ (DraI and BamHI sites underlined). The amplified 
fragment was BamHI/HindIII digested and subcloned into pKars1up, obtaining plasmid pKArsR1. 
The seven arsR1 mutants were independently amplified with a reverse fusion primer 5’-CTC TCC 
ACA CAA TTC AAT TAG CCA ATC-3’ and a forward primer 5’-TAA TTT AAA GGA TCC TCA TAA 
TTC CAT TGA GC-3’ (DraI and BamHI sites underlined), using as template the DNA from plasmids 
pETC15S, pETC16S, pETC55S, pETC15-16S, pETC15/55S, pETC16/55S and pETC15/16/55S, 
respectively. The original ars1 o/p region was amplified with the integrated fusion reverse primer 
(see above) and an integrated fusion forward primer 5’-GAT TGG CTA ATT GAA TTG TGT GGA 
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GAG-3’. Amplified bands from the arsR1 versions and o/p were next used as template for a PCR-
fusion reaction using, in this case, the integrated fusion reverse primer and the forward arsR1 
fusion primer. The seven amplified bands were BamHI/HindIII digested and subcloned into 
pKars1up, generating plasmids pKC15S, pKC16S, pKC55S, pKC15/16S, pKC15/55S, pKC16/55S, 
and pKC15/16/55S. These plasmids were mobilized to C. glutamicum 2∆ars, selecting 
transconjugants by resistance to kanamycin. Integration of suicide plasmids at the correct position 
on the chromosome was determined by PCR and Southern analysis. The resulting strains were 
termed C. glutamicum 2∆arswt, C15S, C16S, C55S C15/16S, C15/55S, C16/55S and C15/16/55S, 
respectively, based on integration of the equivalent plasmid 
 To quantify the efficiency of ars1 gene expression in vivo, plasmid pECGFPars was 
constructed.  This is a pECM2-derivative bifunctional plasmid that contains the main regulatory 
region of the ars1 operon, o/parsB, fused to the egfp2 reporter gene (28), instead of the original arsB 
gene. The 881-bp band containing the indicated construction (o/parsB-egfp2) was PCR-amplified from 
plasmid pEGFP-EP (13), using a forward arsB primer 5’-TAA TTT AAA GAA TTC ATC ACT GGA 
CAG GGG TC-3’ (DraI and EcoRI sites underlined) and a reverse egfp2 primer 5’-TAA TTT AAA 
CTC GAG TTA CTT GTA CAG CTC-3’ (DraI and XhoI sites underlined). The amplified band was 
purified, DraI digested and further subcloned into SmaI digested and dephosphorylated pECM2, 
creating plasmid pECGFPars. This plasmid was independently mobilized to the eight C. 
glutamicum strains containing the arsR1 variants (2∆arswt, C15S, C16S, C55S, C15/16S, C15/55S, 
C16/55S and C15/16/55S), selecting transconjugants by chloramphenicol resistance. For in vivo 
expression analysis under various culture conditions such as the presence of metalloid, strains were 
cultured in TSA medium containing various concentrations of arsenite or antimonite for 24 hr. The 
cells were recovered and suspended in 0.9% NaCl at an A600nm of 0.2. Fluorescence was determined 
with a Synergy HT multidetection microplate reader fluorimeter (Bio-Tek Instruments, Inc.), as 
described (21). 
 
